Ford Airbag Settlement Results in $300M in Payments for Owners With Recalled Takata Inflators

Certain owners of Ford vehicles with recalled Takata airbags, which may rupture and send shrapnel debris into the passenger compartment in the event of a crash, will share in nearly $300 million in compensation the American auto maker has agreed to pay to resolve economic-loss lawsuits.

The Ford airbag settlement was announced in a court filing on Monday, providing at least $299.1 million for expenses incurred by owners or leaseholders of certain vehicles, as well as a rental program to provide loaner vehicles while awaiting airbag repairs or replacement.

Defective Takata airbag inflators were used in more than 6 million Ford cars and trucks, which have been linked to reports of severe injuries and deaths after airbags overinflated and exploded following an auto accident. The settlement does not resolve personal injury and wrongful death lawsuits against Ford over the airbags.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The Takata airbag recall is the largest and most complex in U.S. history, impacting vehicles manufactured by at least 19 different auto makers. In addition to Ford, similar settlements have been reached by Toyota, Subaru, Mazda, BMW, Nissan and other companies. However, General Motors, Fiat Chrysler, Volkswagen and Mercedes-Benz continue to litigate the claims, according to recent reports.

The airbag problems pose the greatest risk in areas with hot temperatures and high humidity, and government officials have recently expressed concerns that nearly 500,000 vehicles located in just the Broward and Miami-Dade counties of southern Florida, nearest the equator, have not yet been repaired.

In February 2018, a rare “Do Not Drive” warning was issued by the U.S. National Highway Traffic Safety Administration (NHTSA) for more than 35,000 Ford and Mazda vehicles with recalled airbags, due to testing that revealed the Takata inflators may spontaneously rupture, even if the vehicle is not involved in a crash.

Lawsuits over recalled Takata airbags filed throughout the federal court system have all be centralized in the U.S. District Court for the Southern District of Florida, as part of a multidistrict litigation, or MDL.

2 Comments

  • RhondaJanuary 16, 2019 at 8:26 pm

    when will I get my settlement money for my Ford fusion 2007 airbag. I file and sent my application 8-2018.

  • LeoraNovember 16, 2018 at 9:44 am

    My car is part of this, we have till the 26th to opt out.. is it better to go with a private lawyer or the class action? Thanks

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted yesterday)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 2 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.